Status:
TERMINATED
Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)
Lead Sponsor:
University Hospital of North Norway
Collaborating Sponsors:
Oslo University Hospital
University of Tromso
Conditions:
Prostate Cancer
Physical Activity
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Previous research into metabolic and hypoxic markers has found evidence of preclinical impact of exercise on prostate tumor blood flow and oxygenation in rodents . As radiotherapy is a frequently used...
Detailed Description
A randomized controlled trial with four to five weeks of moderate/high intensity aerobic exercise program compared with no intervention for 32 prostate cancer patients waiting for radical prostatectom...
Eligibility Criteria
Inclusion
- diagnosed PC
- planned radical prostatectomy
- informed consent given
- above 18 years of age
- BMI \< 30
- non-smoker
- living in Tromso region
Exclusion
- Contraindications to the intervention like;
- heart failure,
- angina pectoris,
- respiratory disease limiting possible intervention
- use of physical supportive devices to aid movement
- High level of physical activity
- smoking
- BMI\>30
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 5 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03365076
Start Date
May 1 2018
End Date
January 5 2023
Last Update
January 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Norway, 9038